South Africa has put a hold on the rollout of the AstraZeneca COVID-19 vaccine.
Health Minister Dr Zweli Mkhize last night announced that a team of experts would give guidance on the way forward with this vaccine.
Early scientific data released on Sunday revealed that the vaccine offered “minimal protection” against mild disease for people infected with the second variant of the coronavirus discovered at the end of last year.
Clinical trial data from the AstraZeneca COVID-19 vaccine study locally revealed that it had a 22% efficacy against the 501Y.V2 coronavirus variant.
Minister Mkhize said that at the time that government acquired the vaccines, this clinical trial data had not been concluded.
More Stories
Independent Advocate Appointed To Probe Fritz Claims
Oldest District Six Claimant Dies Before Returning Home
IPID Lays Charges Against Police Boss Sitole
NICD Reports 4 514 New COVID-19 Cases
Scopa Looks Into Alleged Use Of Public Funds For ANC Activities
386 People Referred For Prosecution For COVID Tender Fraud – SIU
Families Of Trapped Lily Mine Workers Feel Betrayed By Government
NICD Reports 3 197 New COVID-19 Cases
Stats SA To Spend R3.2 Billion On Nationwide Census
Ramaphosa Authorises Release Of Report On COVID Procurement Contracts
ANC MP Mervyn Dirks To Challenge His Suspension
NICD Reports 1 332 New COVID-19 Cases In SA